Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Derhaschnig

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Clinical Chemistry|October 31, 2002
Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency roomUlla Derhaschnig, Anton N Laggner, Martin Röggla, et al.
American Journal of Hypertension|April 10, 2002
Increased levels of transforming growth factor-beta1 in essential hypertensionUlla Derhaschnig, Medhat Shehata, Harald Herkner, et al.
Frontiers in Medicine|January 6, 2025
Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trialMiriam M Moser, Renate Thalhammer, Christian Sillaber, et al.
Thrombosis and Haemostasis|January 26, 2013
Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or bloodSabine Knappe, Monika E Gorczyca, Bernd Jilma, et al.
European Journal of Clinical Investigation|October 10, 2015
Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteersEva-Luise Hobl, Birgit Reiter, Christian Schoergenhofer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 24, 2015
Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteersEva-Luise Hobl, Birgit Reiter, Christian Schoergenhofer, et al.
British Journal of Clinical Pharmacology|January 9, 2020
Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose-escalating trialNina Buchtele, Michael Schwameis, Christian Schoergenhofer, et al.
Pharmacological Research|September 20, 2017
Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemiaJohann Bartko, Ulla Derhaschnig, Tania Neels, et al.
Critical Care Medicine|March 11, 2003
Factors influencing the accuracy of oscillometric blood pressure measurement in critically ill patientsAndreas Bur, Harald Herkner, Marianne Vlcek, et al.
Clinical Science (London, England : 1979)|November 11, 2015
Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trialChristian Schoergenhofer, Michael Schwameis, Eva-Luise Hobl, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|October 31, 2002
Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency roomUlla Derhaschnig, Anton N Laggner, Martin Röggla, et al.
American Journal of Hypertension|April 10, 2002
Increased levels of transforming growth factor-beta1 in essential hypertensionUlla Derhaschnig, Medhat Shehata, Harald Herkner, et al.
Frontiers in Medicine|January 6, 2025
Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trialMiriam M Moser, Renate Thalhammer, Christian Sillaber, et al.
Thrombosis and Haemostasis|January 26, 2013
Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or bloodSabine Knappe, Monika E Gorczyca, Bernd Jilma, et al.
European Journal of Clinical Investigation|October 10, 2015
Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteersEva-Luise Hobl, Birgit Reiter, Christian Schoergenhofer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 24, 2015
Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteersEva-Luise Hobl, Birgit Reiter, Christian Schoergenhofer, et al.
British Journal of Clinical Pharmacology|January 9, 2020
Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose-escalating trialNina Buchtele, Michael Schwameis, Christian Schoergenhofer, et al.
Pharmacological Research|September 20, 2017
Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemiaJohann Bartko, Ulla Derhaschnig, Tania Neels, et al.
Critical Care Medicine|March 11, 2003
Factors influencing the accuracy of oscillometric blood pressure measurement in critically ill patientsAndreas Bur, Harald Herkner, Marianne Vlcek, et al.
Clinical Science (London, England : 1979)|November 11, 2015
Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trialChristian Schoergenhofer, Michael Schwameis, Eva-Luise Hobl, et al.
Pageof 6